Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients

被引:5
作者
Romano, Silvio [1 ]
Necozione, Stefano [1 ]
Guarracini, Leonello [2 ]
Fratini, Simona [1 ]
Cisternino, Pasquale [2 ]
di Orio, Ferdinando [1 ]
Penco, Maria [1 ]
机构
[1] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy
[2] Umberto Hosp, Div Cardiac Rehabil, Laquila, Italy
关键词
brain natriuretic peptides; echocardiography; heart failure; left ventricular dysfunction; CHRONIC HEART-FAILURE; SYSTOLIC DYSFUNCTION; GENERAL-POPULATION; COST-EFFECTIVENESS; COMMUNITY; DISEASE; BNP; DIAGNOSIS; ECHOCARDIOGRAPHY; HYPERTROPHY;
D O I
10.2459/JCM.0b013e3283212ee0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The role of natriuretic peptides in the screening of left ventricular dysfunction is still unclear. The aim of this study was to assess the usefulness of N-terminal pro-brain natriuretic pepticle (NT-proBNP) measurement in asymptomatic patients at high risk of developing left ventricular dysfunction. Methods One hundred and thirty-four consecutive ambulatory patients (mean age 56.1 +/- 7 years) were studied and selected on the basis of a history of hypertension of at least 5 years. Systolic dysfunction was defined as an ejection fraction of 45% or less. Statistical analysis was performed by both parametric and nonparametric approaches. Diagnostic accuracy was evaluated by receiver operating characteristic analysis. Results Echocardiography showed normal left ventricular function in 40 patients, diastolic dysfunction in 80 patients and systolic dysfunction in 14 patients. NT-proBNP levels were significantly higher in patients with systolic dysfunction (356.1 +/- 294.8 vs. 85.2 +/- 85.8 pg/ml; P<0.05). Receiver operating characteristic analysis showed a high value of the area under the curve (0.89) for the detection of systolic dysfunction with a sensitivity of 83% and aspecificity of 80% for a cut-off value of 114 pg/ml and with a negative predictive value of 0.98. Conclusion In asymptomatic patients at high risk for heart failure because of a history of hypertension, the measurement of NT-proBNP levels may represent a useful screening test for left ventricular systolic dysfunction. Therefore, more expensive examinations, such as echocardiography, may be restricted only to patients with higher NT-proBNP levels. J Cardiovasc Med 10:238-244 (C) 2009 Italian Federation of Cardiology.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 37 条
  • [1] B-type natriuretic peptide and ischemia in patients with stable coronary disease - Data from the Heart and Soul Study
    Bibbins-Domingo, K
    Ansari, M
    Schiller, NB
    Massie, B
    Whooley, MA
    [J]. CIRCULATION, 2003, 108 (24) : 2987 - 2992
  • [2] ESTIMATING CLINICAL MORBIDITY DUE TO ISCHEMIC-HEART-DISEASE AND CONGESTIVE-HEART-FAILURE - THE FUTURE RISE OF HEART-FAILURE
    BONNEUX, L
    BARENDREGT, JJ
    MEETER, K
    BONSEL, GJ
    van der Maas, PJ
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (01) : 20 - 28
  • [3] Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature
    Brunner, F
    Wölkart, G
    [J]. CARDIOVASCULAR RESEARCH, 2001, 51 (03) : 577 - 584
  • [4] Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community - Determinants and detection of left ventricular dysfunction
    Costello-Boerrigter, LC
    Boerrigter, G
    Redfield, MM
    Rodeheffer, RJ
    Urban, LH
    Mahoney, DW
    Jacobsen, SJ
    Heublein, DM
    Burnett, JC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (02) : 345 - 353
  • [5] B-type natriuretic peptide in cardiovascular disease
    de Lemos, JA
    McGuire, DK
    Drazner, MH
    [J]. LANCET, 2003, 362 (9380) : 316 - 322
  • [6] Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study
    De Sutter, J
    De Bacquer, D
    Cuypers, S
    Delanghe, J
    De Buyzere, M
    Kornitzer, M
    De Backer, G
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (24) : 2644 - 2649
  • [7] A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: The Strong Heart Study
    Devereux, RB
    Roman, MJ
    Paranicas, M
    Lee, ET
    Welty, TK
    Fabsitz, RR
    Robbins, D
    Rhoades, ER
    Rodeheffer, RJ
    Cowan, LD
    Howard, BV
    [J]. AMERICAN HEART JOURNAL, 2001, 141 (03) : 439 - 446
  • [8] GHJALI JK, 1990, ARCH INTERN MED, V150, P769
  • [9] Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction
    Goetze, Jens Peter
    Mogelvang, Rasmus
    Maage, Lars
    Scharling, Henrik
    Schnohr, Peter
    Sogaard, Peter
    Rehfeld, Jens F.
    Jensen, Jan Skov
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (24) : 3004 - 3010
  • [10] Coronary artery disease, heart failure, and cardiac natriuretic peptides in the middle
    Goetze, JP
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (24) : 2603 - 2604